We found that inhibition of MEF2A in iPSC-CMs resulted in significant downregulation of gene expression associated with cardiomyopathy, which was consistent with the terms associated with MEF2-regulated-genes discovered in perinatal transitions (Fig. 6C and Supplementary Fig. S5A). This evidence concerns the gene MEF2A and cardiomyopathy.